Terms ending in 2033
Every in-force patent on Quiapeg Pharmaceuticals AB's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,773,219 | Functionalized Polymers In force · High confidence | Quiapeg Pharmaceuticals AB | In force | High confidence | |
| US 9,220,789 | Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers In force · High confidence | Quiapeg Pharmaceuticals AB | In force | High confidence | |
| US 10,207,007 | Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers In force · High confidence | Quiapeg Pharmaceuticals AB | In force | High confidence | |
| US 10,383,946 | Conjugates of Biologically Active Molecules to Functionalized Polymers In force · High confidence | Quiapeg Pharmaceuticals AB | In force | High confidence | |
| US 10,653,788 | Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers In force · High confidence | Quiapeg Pharmaceuticals AB | In force | High confidence | |
| US 11,510,989 | Conjugates of Biologically Active Molecules to Functionalized Polymers In force · High confidence | Quiapeg Pharmaceuticals AB | In force | High confidence | |
| US 11,723,981 | Conjugates of Tumor Necrosis Factor Inhibitors to Functionalized Polymers In force · High confidence | Quiapeg Pharmaceuticals AB | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.